Phase 2b Study of VELCADE Alone and VELCADE Plus Irinotecan in Patients With Relapsed or Refractory Colorectal Carcinoma

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2002
The purpose of this study is to evaluate how tumors in patients with colorectal carcinoma respond to treatment with VELCADE alone versus VELCADE given with irinotecan, and also to see what effects (good and bad) it has on you and your cancer.
Epistemonikos ID: 299c5240b6184220e61cf878e2c5127da7249f19
First added on: May 04, 2024